Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Pulmonary Hypertension

  Free Subscription


Articles published in Eur Respir J

Retrieve available abstracts of 118 articles:
HTML format
Text format



Single Articles


    June 2019
  1. JAAFAR S, Visovatti S, Young A, Huang S, et al
    Impact of the Revised Hemodynamic Definition on the Diagnosis of Pulmonary Hypertension in Patients with Systemic Sclerosis.
    Eur Respir J. 2019 Jun 13. pii: 13993003.00586-2019.
    PubMed     Text format     Abstract available


  2. MARON BA, Choudhary G, Tedford RJ, Brittain E, et al
    Correspondence on the debate regarding the haemodynamic definition of pulmonary hypertension.
    Eur Respir J. 2019;53.
    PubMed     Text format    


    May 2019
  3. GALAMBOS C, Mullen MP, Shieh JT, Schwerk N, et al
    Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and pediatric pulmonary hypertension.
    Eur Respir J. 2019 May 31. pii: 13993003.01965-2018.
    PubMed     Text format     Abstract available


  4. ULRICH S, Saxer S, Hasler ED, Schwarz EI, et al
    Effect of domiciliary oxygen therapy on exercise capacity and quality of life in patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomised, placebo-controlled trial.
    Eur Respir J. 2019 May 9. pii: 13993003.002762019.
    PubMed     Text format     Abstract available


  5. TELLO K, Ghofrani HA, Heinze C, Krueger K, et al
    A simple echocardiographic estimate of right ventricular-arterial coupling to assess severity and outcome in pulmonary hypertension on chronic lung disease.
    Eur Respir J. 2019 May 9. pii: 13993003.02435-2018.
    PubMed     Text format    


  6. MCCORMACK MC, Mathai SC
    A crossroads between the heart and lungs: air pollution and pulmonary hypertension.
    Eur Respir J. 2019;53.
    PubMed     Text format    


  7. LANG IM, Matsubara H
    Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension: is Europe behind?
    Eur Respir J. 2019;53.
    PubMed     Text format    


    April 2019
  8. BRENOT P, Jais X, Taniguchi Y, Alonso CG, et al
    French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2019 Apr 25. pii: 13993003.02095-2018.
    PubMed     Text format     Abstract available


  9. PICHL A, Sommer N, Bednorz M, Seimetz M, et al
    Riociguat for treatment of pulmonary hypertension in COPD - a translational study.
    Eur Respir J. 2019 Apr 7. pii: 13993003.02445-2018.
    PubMed     Text format     Abstract available


    March 2019
  10. HUMBERT M, Farber HW, Ghofrani HA, Benza RL, et al
    Risk Assessment in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension.
    Eur Respir J. 2019 Mar 28. pii: 13993003.02004-2018.
    PubMed     Text format     Abstract available


  11. CASCINO TM, McLaughlin VV, Richardson CR, Behbahani-Nejad N, et al
    Physical activity and quality of life in patients with pulmonary hypertension.
    Eur Respir J. 2019 Mar 17. pii: 13993003.00028-2019.
    PubMed     Text format    


  12. GERGES C, Gerges M, Lang IM
    Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes.
    Eur Respir J. 2019;53.
    PubMed     Text format    


  13. GRIGNOLA JC, Trujillo P, Domingo E
    Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes.
    Eur Respir J. 2019;53.
    PubMed     Text format    


  14. GIBBS JSR, Torbicki A
    Proposed new pulmonary hypertension definition: is 4 mm(Hg) worth re-writing medical textbooks?
    Eur Respir J. 2019;53.
    PubMed     Text format    


  15. HOEPER MM, Humbert M
    The new haemodynamic definition of pulmonary hypertension: evidence prevails, finally!
    Eur Respir J. 2019;53.
    PubMed     Text format    


    January 2019
  16. NEWNHAM M, South K, Bleda M, Auger WR, et al
    The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2019 Jan 17. pii: 13993003.01805-2018.
    PubMed     Text format     Abstract available


    December 2018
  17. GRUNIG E, Eichstaedt C, Barbera JA, Benjamin N, et al
    ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension.
    Eur Respir J. 2018 Dec 21. pii: 13993003.00332-2018.
    PubMed     Text format     Abstract available


  18. EYRIES M, Montani D, Nadaud S, Girerd B, et al
    Widening the landscape of heritable pulmonary hypertension mutations in pediatric and adult cases.
    Eur Respir J. 2018 Dec 21. pii: 13993003.01371-2018.
    PubMed     Text format     Abstract available


  19. GALIE N, McLaughlin VV, Rubin LJ, Simonneau G, et al
    An overview of the 6th World Symposium on Pulmonary Hypertension.
    Eur Respir J. 2018 Dec 14. pii: 13993003.02148-2018.
    PubMed     Text format    


  20. NATHAN SD, Barbera JA, Gaine SP, Harari S, et al
    Pulmonary hypertension in chronic lung disease and hypoxia.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01914-2018.
    PubMed     Text format     Abstract available


  21. HOEPER MM, Benza RL, Corris P, de Perrot M, et al
    Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01906-2018.
    PubMed     Text format     Abstract available


  22. MCGOON MD, Ferrari P, Armstrong I, Denis M, et al
    The importance of patient perspectives in pulmonary hypertension.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01919-2018.
    PubMed     Text format     Abstract available


  23. VONK NOORDEGRAAF A, Chin KM, Haddad F, Hassoun PM, et al
    Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01900-2018.
    PubMed     Text format     Abstract available


  24. VACHIERY JL, Tedford RJ, Rosenkranz S, Palazzini M, et al
    Pulmonary hypertension due to left heart disease.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01897-2018.
    PubMed     Text format     Abstract available


  25. FROST A, Badesch D, Gibbs JSR, Gopalan D, et al
    Diagnosis of pulmonary hypertension.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01904-2018.
    PubMed     Text format     Abstract available


  26. HUMBERT M, Guignabert C, Bonnet S, Dorfmuller P, et al
    Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01887-2018.
    PubMed     Text format     Abstract available


  27. KIM NH, Delcroix M, Jais X, Madani MM, et al
    Chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01915-2018.
    PubMed     Text format     Abstract available


  28. SIMONNEAU G, Montani D, Celermajer DS, Denton CP, et al
    Haemodynamic definitions and updated clinical classification of pulmonary hypertension.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01913-2018.
    PubMed     Text format     Abstract available


    November 2018
  29. KLOK FA, Barco S, Konstantinides SV, Dartevelle P, et al
    Determinants of diagnostic delay in Chronic Thromboembolic Pulmonary Hypertension: results from the European CTEPH registry.
    Eur Respir J. 2018 Nov 8. pii: 13993003.01687-2018.
    PubMed     Text format    


  30. SWIETLIK EM, Ruggiero A, Fletcher AJ, Taboada D, et al
    Limitations of resting haemodynamics in chronic thromboembolic disease without pulmonary hypertension.
    Eur Respir J. 2018 Nov 8. pii: 13993003.01787-2018.
    PubMed     Text format    


    October 2018
  31. DELCROIX M, Staehler G, Gall H, Grunig E, et al
    Risk assessment in medically treated Chronic Thromboembolic Pulmonary Hypertension patients.
    Eur Respir J. 2018 Oct 18. pii: 13993003.00248-2018.
    PubMed     Text format     Abstract available


  32. TURPIN M, Chantalat-Auger C, Parent F, Driss F, et al
    Chronic blood exchange transfusions in the management of pre-capillary pulmonary hypertension complicating sickle cell disease.
    Eur Respir J. 2018;52.
    PubMed     Text format     Abstract available


    September 2018
  33. KIM NH, Mayer E
    Pulmonary endarterectomy and the cost of patient refusal.
    Eur Respir J. 2018;52.
    PubMed     Text format    


    August 2018
  34. GRUNE J, Kuebler WM
    Is there a role for endothelin-1 receptor antagonists in the treatment of lung fibrosis associated with pulmonary hypertension?
    Eur Respir J. 2018;52.
    PubMed     Text format    


    July 2018
  35. SOUMAGNE T, Guillien A, Chambellan A, Hua-Huy T, et al
    Global Lung Initiative equations in pulmonary hypertension screening in systemic sclerosis.
    Eur Respir J. 2018 Jul 26. pii: 13993003.00528-2018.
    PubMed     Text format    


  36. QUADERY SR, Swift AJ, Billings C, Thompson A, et al
    The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2018 Jul 12. pii: 13993003.00589-2018.
    PubMed     Text format     Abstract available


  37. BELLAYE PS, Yanagihara T, Granton E, Sato S, et al
    Macitentan reduces progression of TGF-beta1-induced pulmonary fibrosis and pulmonary hypertension.
    Eur Respir J. 2018 Jul 5. pii: 13993003.01857-2017.
    PubMed     Text format    


    June 2018
  38. BADLAM JB, Austin ED
    Beyond oestrogens: towards a broader evaluation of the hormone profile in pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  39. GUIGNABERT C, de Man F, Lombes M
    ACE2 as therapy for pulmonary arterial hypertension: the good outweighs the bad.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  40. BAIRD GL, Archer-Chicko C, Barr RG, Bluemke DA, et al
    Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


    May 2018
  41. KING CS, Brown AW, Shlobin OA, Weir N, et al
    Prevalence and Impact of WHO Group 3 Pulmonary Hypertension in Advanced Idiopathic Nonspecific Interstitial Pneumonia.
    Eur Respir J. 2018 May 17. pii: 13993003.00545-2018.
    PubMed     Text format    


  42. GUAZZI M
    Partitioning of pulmonary vascular resistances in group 2 pulmonary hypertension: insightful suggestions for bridging haemodynamics to underlying mechanisms.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  43. HOEPER MM, Boucly A, Sitbon O
    Age, risk and outcomes in idiopathic pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    


    April 2018
  44. HOEPER MM
    Chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: to screen or not to screen?
    Eur Respir J. 2018;51.
    PubMed     Text format    


  45. CONDLIFFE R, Kovacs G
    Identifying early pulmonary arterial hypertension in patients with systemic sclerosis.
    Eur Respir J. 2018;51.
    PubMed     Text format    


    March 2018
  46. GERGES C, Gerges M, Fesler P, Maria Pistritto A, et al
    In-depth hemodynamic phenotyping of pulmonary hypertension due to left heart disease.
    Eur Respir J. 2018 Mar 29. pii: 13993003.00067-2018.
    PubMed     Text format     Abstract available


  47. COGHLAN G, Wolf M, Distler O, Denton CP, et al
    Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis.
    Eur Respir J. 2018 Mar 21. pii: 13993003.01197-2017.
    PubMed     Text format     Abstract available


  48. BONNET S, Boucherat O
    The ROS controversy in hypoxic pulmonary hypertension revisited.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  49. OLSCHEWSKI H, Kovacs G, Herve P
    Pulmonary capillary recruitment in exercise and pulmonary hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  50. LANGLEBEN D, Orfanos SE
    Pulmonary capillary recruitment in exercise and pulmonary hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  51. BOUCLY A, Weatherald J, Humbert M, Sitbon O, et al
    Risk assessment in pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  52. HOEPER MM, Pittrow D, Opitz C, Gibbs JSR, et al
    Risk assessment in pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  53. DACCORD C, Letovanec I, Yerly P, Bloch J, et al
    First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    


    February 2018
  54. CARAVITA S, Dewachter C, Soranna D, Carolino D'Araujo S, et al
    Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: a meta-analysis.
    Eur Respir J. 2018 Feb 8. pii: 13993003.02427-2017.
    PubMed     Text format    


  55. PAK O, Scheibe S, Esfandiary A, Gierhardt M, et al
    Impact of the mitochondria-targeted antioxidant MitoQ on hypoxia-induced pulmonary hypertension.
    Eur Respir J. 2018 Feb 1. pii: 13993003.01024-2017.
    PubMed     Text format     Abstract available


  56. HSU S, Tedford RJ
    Will we be singing a different tune on combined post- and pre-capillary pulmonary hypertension?
    Eur Respir J. 2018;51.
    PubMed     Text format    


  57. VACHIERY JL, Delcroix M, Al-Hiti H, Efficace M, et al
    Macitentan in pulmonary hypertension due to left ventricular dysfunction.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


    January 2018
  58. TRAMPER J, Nossent EJ, Lely RJ, Krouwels FH, et al
    Balloon pulmonary angioplasty in sarcoid-related pulmonary hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  59. COTTIN V, Price LC, Valenzuela C
    The unmet medical need of pulmonary hypertension in idiopathic pulmonary fibrosis.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  60. KUMAR R, Graham B
    How does inflammation contribute to pulmonary hypertension?
    Eur Respir J. 2018;51.
    PubMed     Text format    


    October 2017
  61. BAUGHMAN RP, Shlobin OA
    Treatment of sarcoidosis-associated pulmonary hypertension: so close, and yet so far.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  62. DEGANO B, Soumagne T, Delaye T, Berger P, et al
    Combined measurement of carbon monoxide and nitric oxide lung transfer does not improve the identification of pulmonary hypertension in systemic sclerosis.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  63. BOUCLY A, Cottin V, Nunes H, Jais X, et al
    Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    September 2017
  64. WEATHERALD J, Boucly A, Lau E, Godinas L, et al
    Are indexed values better for defining exercise pulmonary hypertension?
    Eur Respir J. 2017;50.
    PubMed     Text format    


  65. MULLIN CJ, Hsu S, Amancherla K, Wand A, et al
    Evaluation of criteria for exercise-induced pulmonary hypertension in patients with resting pulmonary hypertension.
    Eur Respir J. 2017;50.
    PubMed     Text format    


    August 2017
  66. HOEPER MM, Kramer T, Pan Z, Eichstaedt CA, et al
    Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    July 2017
  67. BOGAARD HJ
    Hypoxic pulmonary vasoconstriction in COPD-associated pulmonary hypertension: been there, done that?
    Eur Respir J. 2017;50.
    PubMed     Text format    


    June 2017
  68. OLSSON KM, Wiedenroth CB, Kamp JC, Breithecker A, et al
    Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    May 2017
  69. JOUNEAU S, Ballerie A, Kerjouan M, Demant X, et al
    Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  70. SANGES S, Prevotat A, Fertin M, Terriou L, et al
    Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  71. KLOK FA, Hoeper MM
    Predicting recurrent pulmonary embolism and chronic thromboembolic pulmonary hypertension: one more way to skin the cat.
    Eur Respir J. 2017;49.
    PubMed     Text format    


    March 2017
  72. NEDER JA, Berton DC, Arbex FF, Alencar MC, et al
    Physiological and clinical relevance of exercise ventilatory efficiency in COPD.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    February 2017
  73. SCHERRER U, Verges S
    Sleep apnoea and pulmonary hypertension in high-altitude dwellers: more than an association?
    Eur Respir J. 2017;49.
    PubMed     Text format    


  74. SIMONNEAU G, Hoeper MM
    Evaluation of the incidence of rare diseases: difficulties and uncertainties, the example of chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  75. ENDE-VERHAAR YM, Cannegieter SC, Vonk Noordegraaf A, Delcroix M, et al
    Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  76. NAKHLEH MK, Haick H, Humbert M, Cohen-Kaminsky S, et al
    Volatolomics of breath as an emerging frontier in pulmonary arterial hypertension.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    December 2016
  77. LATSHANG TD, Furian M, Aeschbacher SS, Ulrich S, et al
    Association between sleep apnoea and pulmonary hypertension in Kyrgyz highlanders.
    Eur Respir J. 2016 Dec 22. pii: 1601530. doi: 10.1183/13993003.01530-2016.
    PubMed     Text format     Abstract available


    November 2016
  78. RIOU M, Seferian A, Savale L, Chaumais MC, et al
    Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity.
    Eur Respir J. 2016;48:1517-1519.
    PubMed     Text format    


    October 2016
  79. EID-LIDT G, Gaspar J, Sandoval J, Gonzalez-Pacheco H, et al
    Persistent pulmonary hypertension and right ventricular function after percutaneous mechanical thrombectomy in severe acute pulmonary embolism.
    Eur Respir J. 2016 Oct 20. pii: ERJ-00910-2016. doi: 10.1183/13993003.00910-2016
    PubMed     Text format    


    September 2016

  80. "New potential diagnostic biomarkers for pulmonary hypertension." Svenja L. Tiede, Henning Gall, Oliver Dorr, Marina dos Santos Guilherme, Christian Troidl, Christoph Liebetrau, Sandra Voss, Robert Voswinckel, Ralph T. Schermuly, Werner Seeger, Friedr
    Eur Respir J. 2016;48:962.
    PubMed     Text format    


  81. LEVY M, Eyries M, Szezepanski I, Ladouceur M, et al
    Genetic analyses in a cohort of children with pulmonary hypertension.
    Eur Respir J. 2016 Sep 1. pii: ERJ-00211-2016. doi: 10.1183/13993003.00211-2016.
    PubMed     Text format     Abstract available


    August 2016
  82. NAGARAJ C, Tang B, Nagy BM, Papp R, et al
    Docosahexaenoic acid causes rapid pulmonary arterial relaxation via KCa channel-mediated hyperpolarisation in pulmonary hypertension.
    Eur Respir J. 2016 Aug 18. pii: ERJ-01814-2015. doi: 10.1183/13993003.01814-2015
    PubMed     Text format     Abstract available


  83. GAMEN E, Seeger W, Pullamsetti SS
    The emerging role of epigenetics in pulmonary hypertension.
    Eur Respir J. 2016 Aug 4. pii: ERJ-01714-2015. doi: 10.1183/13993003.01714-2015.
    PubMed     Text format     Abstract available



  84. ERJ August Podcast: management of chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2016;48:E68.
    PubMed     Text format    


    July 2016
  85. PARPALEIX A, Amsellem V, Houssaini A, Abid S, et al
    Role of interleukin-1 receptor 1/MyD88 signalling in the development and progression of pulmonary hypertension.
    Eur Respir J. 2016 Jul 13. pii: ERJ-01448-2015. doi: 10.1183/13993003.01448-2015
    PubMed     Text format     Abstract available


    June 2016
  86. HASSOUN PM, Nathan SD
    Sildenafil for pulmonary hypertension complicating idiopathic pulmonary fibrosis: a rationale grounded in basic science.
    Eur Respir J. 2016;47:1615-7.
    PubMed     Text format    


    May 2016
  87. GERGES M, Gerges C, Lang IM
    How to define pulmonary hypertension due to left heart disease.
    Eur Respir J. 2016 May 12. pii: ERJ-00432-2016. doi: 10.1183/13993003.00432-2016
    PubMed     Text format    


    April 2016
  88. HOFFMANN J, Wilhelm J, Olschewski A, Kwapiszewska G, et al
    Microarray analysis in pulmonary hypertension.
    Eur Respir J. 2016 Apr 13. pii: ERJ-02030-2015. doi: 10.1183/13993003.02030-2015
    PubMed     Text format     Abstract available


  89. NEDER JA, Ramos RP, Ota-Arakaki JS, Ferreira EM, et al
    Insights into ventilation-gas exchange coupling in chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2016 Apr 13. pii: ERJ-01948-2015. doi: 10.1183/13993003.01948-2015
    PubMed     Text format    


  90. MATHAI SC, Ghofrani HA, Mayer E, Pepke-Zaba J, et al
    Quality of life in patients with chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2016 Apr 13. pii: ERJ-01626-2015. doi: 10.1183/13993003.01626-2015
    PubMed     Text format     Abstract available


  91. OLIVEIRA RK, Agarwal M, Tracy JA, Karin AL, et al
    Age-related upper limits of normal for maximum upright exercise pulmonary haemodynamics.
    Eur Respir J. 2016;47:1179-88.
    PubMed     Text format     Abstract available


    March 2016
  92. GODINAS L, Lau EM, Chemla D, Lador F, et al
    Diagnostic concordance of different criteria for exercise pulmonary hypertension in subjects with normal resting pulmonary artery pressure.
    Eur Respir J. 2016 Mar 30. pii: ERJ-01678-2015. doi: 10.1183/13993003.01678-2015
    PubMed     Text format    


  93. MILARA J, Escriva J, Ortiz JL, Juan G, et al
    Vascular effects of sildenafil in patients with pulmonary fibrosis and pulmonary hypertension: an ex vivo/in vitro study.
    Eur Respir J. 2016 Mar 23. pii: ERJ-01259-2015. doi: 10.1183/13993003.01259-2015
    PubMed     Text format     Abstract available


    February 2016
  94. LAHM T
    Sex differences in pulmonary hypertension: are we cleaning up the mess?
    Eur Respir J. 2016;47:390-3.
    PubMed     Text format    


  95. TOSHNER M
    Genetic testing in pulmonary hypertension: how should our clinical practice reflect recent advances?
    Eur Respir J. 2016;47:388-9.
    PubMed     Text format    


  96. MALENFANT S, Perros F
    beta-blockers in pulmonary arterial hypertension: generation might matter.
    Eur Respir J. 2016;47:682-4.
    PubMed     Text format    


  97. PRICE LC, Wort SJ
    Earlier diagnosis and international registries may improve outcomes in pulmonary tumour thrombotic microangiopathy.
    Eur Respir J. 2016;47:690-1.
    PubMed     Text format    


  98. MERAD M, Savale L, Antoun S, Vincent F, et al
    Is there hope of improving the prognosis of pulmonary tumour thrombotic microangiopathy?
    Eur Respir J. 2016;47:688-90.
    PubMed     Text format    


  99. PUENTE-MAESTU L, Palange P, Casaburi R, Laveneziana P, et al
    Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement.
    Eur Respir J. 2016;47:429-60.
    PubMed     Text format     Abstract available


  100. RODRIGUEZ-ROISIN R, Bartolome SD, Huchon G, Krowka MJ, et al
    Inflammatory bowel diseases, chronic liver diseases and the lung.
    Eur Respir J. 2016;47:638-50.
    PubMed     Text format     Abstract available


    January 2016
  101. KOVACS G, Avian A, Olschewski H
    Proposed new definition of exercise pulmonary hypertension decreases false positive cases.
    Eur Respir J. 2016 Jan 7. pii: ERJ-01394-2015. doi: 10.1183/13993003.01394-2015.
    PubMed     Text format    


  102. QUILOT FM, Georges M, Favrolt N, Beltramo G, et al
    Pulmonary hypertension associated with ponatinib therapy.
    Eur Respir J. 2016 Jan 7. pii: ERJ-01110-2015. doi: 10.1183/13993003.01110-2015.
    PubMed     Text format    


  103. SOMMER N, Strielkov I, Pak O, Weissmann N, et al
    Oxygen sensing and signal transduction in hypoxic pulmonary vasoconstriction.
    Eur Respir J. 2016;47:288-303.
    PubMed     Text format     Abstract available


    December 2015
  104. SABOOR F, Reckmann AN, Tomczyk CU, Peters DM, et al
    Nestin-expressing vascular wall cells drive development of pulmonary hypertension.
    Eur Respir J. 2015 Dec 23. pii: ERJ-00574-2015. doi: 10.1183/13993003.00574-2015
    PubMed     Text format     Abstract available


  105. GIRERD B, Montani D, Jais X, Eyries M, et al
    Genetic counselling in a national referral centre for pulmonary hypertension.
    Eur Respir J. 2015 Dec 23. pii: ERJ-00717-2015. doi: 10.1183/13993003.00717-2015
    PubMed     Text format     Abstract available



  106. "2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)."
    Eur Respir J. 2015;46:1855-6.
    PubMed     Text format    


  107. SAVALE L, Chaumais MC, Sitbon O, Humbert M, et al
    Pulmonary arterial hypertension in patients treated with interferon.
    Eur Respir J. 2015;46:1851-3.
    PubMed     Text format    


  108. PRELLA M, Yerly P, Nicod LP, Aubert JD, et al
    Pulmonary arterial hypertension in patients treated with interferon.
    Eur Respir J. 2015;46:1849-51.
    PubMed     Text format    


    November 2015
  109. BARBERA JA, Blanco I
    Gaining insights into pulmonary hypertension in respiratory diseases.
    Eur Respir J. 2015;46:1247-50.
    PubMed     Text format    


    October 2015
  110. HUITEMA MP, Spee M, Vorselaars VM, Boerman S, et al
    Pulmonary artery diameter to predict pulmonary hypertension in pulmonary sarcoidosis.
    Eur Respir J. 2015 Oct 22. pii: ERJ-01319-2015. doi: 10.1183/13993003.01319-2015
    PubMed     Text format    



  111. ERJ October Podcast: new guidelines for diagnosis and treatment of pulmonary hypertension.
    Eur Respir J. 2015;46:E58.
    PubMed     Text format    


  112. LAU EM, Tamura Y, McGoon MD, Sitbon O, et al
    The 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: a practical chronicle of progress.
    Eur Respir J. 2015;46:879-82.
    PubMed     Text format    


    June 2015
  113. MANDERS E, Ruiter G, Bogaard HJ, Stienen GJ, et al
    Quadriceps muscle fibre dysfunction in patients with pulmonary arterial hypertension.
    Eur Respir J. 2015;45:1737-40.
    PubMed     Text format    


  114. ROBERTSON HT
    Dead space: the physiology of wasted ventilation.
    Eur Respir J. 2015;45:1704-16.
    PubMed     Text format     Abstract available


    April 2015
  115. HUERTAS A, Tu L, Thuillet R, Le Hiress M, et al
    Leptin signalling system as a target for pulmonary arterial hypertension therapy.
    Eur Respir J. 2015;45:1066-80.
    PubMed     Text format     Abstract available


    March 2015
  116. HOUSTON BA, Tedford RJ
    Stressing the stepchild: assessing right ventricular contractile reserve in pulmonary arterial hypertension.
    Eur Respir J. 2015;45:604-7.
    PubMed     Text format    


  117. SHARMA T, Lau EM, Choudhary P, Torzillo PJ, et al
    Dobutamine stress for evaluation of right ventricular reserve in pulmonary arterial hypertension.
    Eur Respir J. 2015;45:700-8.
    PubMed     Text format     Abstract available


    January 2015
  118. COURAND PY, Pina Jomir G, Khouatra C, Scheiber C, et al
    Prognostic value of right ventricular ejection fraction in pulmonary arterial hypertension.
    Eur Respir J. 2015;45:139-49.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: